We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $3.18B
1-Year Est. Return 65.92%
This Fund
S&P 500
This Quarter Est. Return
+6.84%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
AUM
$756M
AUM Growth
-$336M
Cap. Flow
-$340M
Cap. Flow %
-44.97%
Top 10 Hldgs %
27.05%
Holding
2,634
New
953
Increased
264
Reduced
302
Closed
1,085

Sector Composition

Rank Sector Weight
1 Financials 27.25%
2 Healthcare 11.84%
3 Technology 9.16%
4 Industrials 6.55%
5 Consumer Discretionary 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVYA
1426
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$7K ﹤0.01%
+36,411
New +$40.7K
NAVB
1427
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$7K ﹤0.01%
33,654
-4,557
-12% -$1.14K
PME
1428
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$7K ﹤0.01%
18,559
-24,637
-57% -$16.9K
CREX icon
1429
Creative Realities
CREX
$43.2M
$6K ﹤0.01%
3,466
-7,989
-70% -$14.6K
FRSX
1430
Foresight Autonomous Holdings
FRSX
$4.02M
$6K ﹤0.01%
+107
New +$7.61K
FURY
1431
Fury Gold Mines
FURY
$116M
$6K ﹤0.01%
12,987
-1,699
-12% -$635
HEPA
1432
DELISTED
Hepion Pharmaceuticals
HEPA
$6K ﹤0.01%
21
-47
-69% -$19.9K
LGMK
1433
DELISTED
LogicMark
LGMK
$6K ﹤0.01%
+25
New +$8.85K
CYPH
1434
Cypherpunk Technologies Inc
CYPH
$69.4M
$6K ﹤0.01%
1,430
-6,332
-82% -$42.3K
REE
1435
DELISTED
REE Automotive
REE
$6K ﹤0.01%
+484
New +$8.02K
SRZN icon
1436
Surrozen
SRZN
$280M
$6K ﹤0.01%
+722
New +$15.3K
NTBL
1437
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$6K ﹤0.01%
1,483
-1,148
-44% -$5.4K
ASTR
1438
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$6K ﹤0.01%
+933
New +$7.33K
AWH
1439
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$6K ﹤0.01%
+1,277
New +$6.98K
UTRS
1440
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$6K ﹤0.01%
+1,452
New +$9.64K
NYMX
1441
DELISTED
Nymox Pharmaceutical Corp
NYMX
$6K ﹤0.01%
+19,646
New +$7.11K
KRBP
1442
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$6K ﹤0.01%
+1,060
New +$8.52K
IONM
1443
DELISTED
Assure Holdings Corp. Common Stock
IONM
$6K ﹤0.01%
67
+18
+37% +$3.36K
SMIT
1444
DELISTED
Schmitt Industries Inc
SMIT
$6K ﹤0.01%
19,698
+3,521
+22% +$4.04K
AKTX
1445
Akari Therapeutics
AKTX
$12.7M
$5K ﹤0.01%
+13
New +$5.38K
EFOI icon
1446
Energy Focus
EFOI
$19.1M
$5K ﹤0.01%
+2,382
New +$6.54K
XTKG
1447
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
BLNE
1448
Beeline Holdings
BLNE
$36.4M
$5K ﹤0.01%
105
-418
-80% -$23.5K
TLIS
1449
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$5K ﹤0.01%
+717
New +$6.29K
ROI
1450
DELISTED
RiskOn International, Inc. Common Stock
ROI
$5K ﹤0.01%
+734
New +$15.2K

Similar funds

Virtu Financial's Q4 2022 Portfolio in Review

As of Q4 2022, Virtu Financial held 2,634 positions worth $756M, down 31% from $1.09B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Virtu Financial withdrew a net $340M in Q4 2022, closing 1,085 positions and reducing 302 holdings. Its most notable exit was Duke Realty Corp., an estimated $33.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Virtu Financial opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $15.9M.

  • Virtu Financial's largest Q4 2022 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 246,884 shares worth $15.9M.
  • Virtu Financial added most to L3Harris in Q4 2022, an estimated $7.23M increase.
  • Virtu Financial's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $21.6M.
  • Virtu Financial fully exited Duke Realty Corp. in Q4 2022, selling an estimated $33.9M.
  • Virtu Financial's ten largest holdings make up 27% of its $756M portfolio in Q4 2022.
  • Virtu Financial opened 953 new positions and closed 1,085 in Q4 2022.
  • Virtu Financial's portfolio value fell 31% quarter-over-quarter to $756M.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.